查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594889

全球狂犬病诊断市场

Rabies Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球狂犬病诊断市场预计将达到 28 亿美元

狂犬病诊断的全球市场预计 2023 年为 19 亿美元，预计到 2030 年将达到 28 亿美元，在 2023-2030 年分析期间复合年增长率为 5.3%。萤光抗体检测 (FAT) 是本报告分析的细分市场之一，预计复合年增长率为 5.1%，到分析期结束时将达到 9.101 亿美元。分析期内，免疫组化检测领域的复合年增长率预计为 5.3%。

美国市场预估为5.127亿美元，中国预期复合年增长率为7.8%

预计 2023 年美国狂犬病诊断市场规模将达 5.127 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达6.023亿美元，2023年至2030年复合年增长率为7.8%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 3.4% 和 4.3%。在欧洲，德国的复合年增长率预计为 3.9%。

狂犬病诊断：确保及时发现并预防这种致命疾病

什么是狂犬病诊断？

狂犬病诊断是指用于检测动物和人类狂犬病病毒的方法和工具。及时诊断至关重要，因为狂犬病在出现症状时几乎总是致命的，但早期发现可以透过及时有效的治疗来预防。狂犬病诊断在公共卫生中发挥重要作用，包括预防疫情、确定治疗策略以及为疫苗接种宣传活动提供资讯。准确的诊断方法还可以帮助兽医和野生动物专业人员识别受感染的动物，并允许采取管理措施来保护人类和动物族群。由于狂犬病会透过被感染动物咬伤的唾液传播，影响中枢神经系统，并且可以传播到几乎所有温血动物，因此有效的治疗对于控制和预防狂犬病传播至关重要。

早期、准确的狂犬病诊断对于评估咬伤受害者的潜在暴露至关重要。如果怀疑患有狂犬病，诊断结果可以帮助确定是否进行暴露后预防（PEP），这是一种在症状出现之前进行的挽救生命的疫苗治疗。狂犬病检测对于清除野生动物和牲畜也至关重要，因为动物，尤其是蝙蝠、浣熊、狐狸和流浪狗等野生物种，是狂犬病的主要携带者。准确的诊断使卫生当局能够开展监测计划，识别有风险的地区，并将预防工作重点放在发病率高的地区。这些措施对于维护公众健康和安全至关重要，特别是在狂犬病仍然流行的地区。

通常使用哪些诊断方法来检测狂犬病？

狂犬病诊断的黄金标准是直接萤光抗体（DFA）测试，可分析动物死后的脑组织。此测试使用萤光标记的抗体，该抗体与狂犬病病毒抗原结合，并且可以直接在显微镜下观察。 DFA 测试仍然是确认动物狂犬病的主要方法，因为它敏感、特异性且能快速提供结果。然而，它是侵入性的，因为它需要脑组织，并且只能在动物死亡后进行，限制其使用案例死亡或安乐死动物的疑似病例。

其他几种诊断方法可用于人类或需要非侵入性测试时。逆转录聚合酵素链锁反应(RT-PCR) 是一种分子技术，可检测唾液、皮肤切片检查和脑脊髓液等检体中是否存在狂犬病病毒 RNA。 RT-PCR 可以对活体患者进行，因此可以提供一种在死亡前检测狂犬病的方法，但它的敏感性不如 DFA，并且可能容易出现假阴性，尤其是在感染的早期阶段。酵素结合免疫吸附检测法(ELISA) 和血清学测试也可用于检测血液中的狂犬病抗体，但这些通常表明过去的暴露情况，而不是诊断活动性性行为感染。结合这些方法将实现更全面的诊断方法，并提高检测和应对动物和人类狂犬病的能力。

狂犬病诊断如何随着新技术的发展而发展？

狂犬病诊断的最新进展集中在提高早期检测的速度、可及性和非侵入性选择。狂犬病快速诊断测试通常基于横向流动化验技术，旨在提供现场快速测试结果，而不需要专门的测试设备。这些快速检测在现场环境中特别有用，因为它们允许兽医和医疗专业人员快速评估疑似病例，并在必要时实施隔离和疫苗接种。儘管不如 DFA 测试准确，但这些携带式诊断仪是初步筛检的宝贵工具，特别是在检测设施有限的农村和资源有限地区。

分子诊断的创新，包括即时PCR和次世代定序，也正在提高检测狂犬病的能力。即时PCR技术可以定量检体中的病毒量，因此即使在病毒量较低的情况下也能进行高灵敏度检测，有助于人类和动物的早期诊断。此外，正在研究开发一种非侵入性诊断方法，利用唾液或眼泪来检测活体动物的狂犬病，从而可以对家养宠物进行早期检测，并预防狂犬病疑似病例，从而可能减少安乐死的需要。随着诊断技术的进步，我们的目标是开发更容易取得、更可靠、更人性化的狂犬病检测方法，以改善不同环境下的疾病控制和预防。

推动狂犬病诊断市场成长的因素有哪些？

狂犬病诊断市场的成长是由狂犬病预防意识的提高、诊断技术的进步以及高风险地区对可用诊断方法的需求不断增加等因素所推动的。随着人们对狂犬病危险和早期诊断重要性的认识不断提高，医疗机构和兽医组织正在优先考虑狂犬病诊断检测，以控制和预防狂犬病的爆发。此外，世界许多地区的快速都市化和人类与野生动物互动的增加增加了狂犬病感染的可能性，并增加了对广泛诊断能力的需求。

此外，技术的进步使得便携式快速检测和分子检测技术可以在现场和临床环境中使用，使狂犬病诊断变得更加容易。这些创新解决了远端检测的挑战，特别是在狂犬病仍然流行的地区，如非洲、亚洲和拉丁美洲。此外，政府和非营利组织正在共同努力减少全球狂犬病，例如世界卫生组织的「零除 30」目标，即到 2030 年消除因狗传播狂犬病造成的人类死亡。狂犬病诊断。这些综合因素正在推动狂犬病诊断市场的成长，并支持全球减少狂犬病感染和改善公共卫生结果的努力。

部分

方法学（萤光抗体检测（FAT）、免疫组织化学、扩增、组织学、血清学）技术（ELISA/免疫组织化学、层析法、PCR、其他技术）；

受访企业举例（共34家）

  • Abbexa Ltd.
  • Aviva Systems Biology Corporation
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Creative Diagnostics
  • Demeditec Diagnostics GmbH
  • Express Biotech International Inc.
  • Merck KGaA
  • MyBioSource.com
  • Norgen Biotek Corp.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP22670

Global Rabies Diagnostics Market to Reach US$2.8 Billion by 2030

The global market for Rabies Diagnostics estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$910.1 Million by the end of the analysis period. Growth in the Immunohistochemical Tests segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$512.7 Million While China is Forecast to Grow at 7.8% CAGR

The Rabies Diagnostics market in the U.S. is estimated at US$512.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$602.3 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Rabies Diagnostics: Ensuring Timely Detection and Prevention of a Deadly Disease

What Are Rabies Diagnostics and Why Are They Critical in Public Health?

Rabies diagnostics refer to the methods and tools used to detect the rabies virus in animals and humans. Timely diagnosis is essential because rabies is nearly always fatal once symptoms appear, but it is preventable with prompt and effective treatment if identified early. Rabies diagnostics play a crucial role in public health by helping prevent outbreaks, guiding treatment decisions, and informing vaccination campaigns. Accurate diagnostic methods also aid veterinarians and wildlife professionals in identifying infected animals, allowing them to implement control measures to protect both human and animal populations. The disease, which is transmitted through saliva from an infected animal bite, affects the central nervous system and can spread to nearly any warm-blooded species, making effective diagnostics vital for controlling and preventing rabies transmission.

Early and precise rabies diagnostics are essential for assessing possible exposure in bite victims. If rabies is suspected, diagnostics help guide the decision to administer post-exposure prophylaxis (PEP), a life-saving vaccine treatment given before symptoms develop. Rabies testing is also crucial in wildlife and domestic animal control, as animals, particularly wild species like bats, raccoons, foxes, and stray dogs, are primary rabies carriers. Through accurate diagnostics, health authorities can implement surveillance programs, identify at-risk areas, and focus preventive efforts on regions with high incidence rates. These actions are critical in maintaining public health and safety, especially in areas where rabies remains endemic.

What Diagnostic Methods Are Commonly Used to Detect Rabies?

The gold standard for rabies diagnosis is the Direct Fluorescent Antibody (DFA) Test, which involves analyzing brain tissue from an animal postmortem. This test uses fluorescently labeled antibodies that bind to rabies virus antigens, allowing for direct visualization under a microscope. The DFA test is highly sensitive and specific, providing results in a short time frame, and remains the primary method for confirming rabies in animals. However, because it requires brain tissue, it is invasive and can only be performed after the animal's death, limiting its use to suspected cases in animals that have died or been euthanized.

For humans and in situations where non-invasive testing is preferred, several other diagnostic methods are used. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a molecular technique that detects the presence of rabies virus RNA in samples like saliva, skin biopsies, and cerebrospinal fluid. RT-PCR can be performed on living patients, providing a way to detect rabies before death, though it is less sensitive than DFA and can yield false negatives, especially in early stages of infection. Enzyme-Linked Immunosorbent Assay (ELISA) and serological tests are also used to detect rabies antibodies in blood, though they are typically more useful for confirming previous exposure rather than diagnosing active infection. Combined, these methods enable a more comprehensive diagnostic approach, enhancing the ability to detect and respond to rabies in both animals and humans.

How Are Rabies Diagnostics Evolving with New Technology?

Recent advancements in rabies diagnostics focus on improving speed, accessibility, and non-invasive options for early detection. Rapid rabies diagnostic tests, often based on lateral flow assay technology, have been developed to provide quick, on-site testing results without the need for specialized laboratory equipment. These rapid tests are particularly useful in field settings, allowing veterinarians and health professionals to assess suspected cases quickly and implement quarantine or vaccination measures as needed. Although not as precise as the DFA test, these portable diagnostics offer a valuable tool for preliminary screening, especially in rural or resource-limited areas where access to laboratory facilities may be limited.

Innovations in molecular diagnostics, including real-time PCR and next-generation sequencing, are also enhancing rabies detection capabilities. Real-time PCR techniques can quantify viral load in samples, providing more sensitive detection even at lower viral levels, which is beneficial for early diagnosis in humans and animals. Additionally, research is ongoing into developing non-invasive diagnostic methods that use saliva or tears to detect rabies in living animals, which could potentially enable early detection in domestic pets and reduce the need for euthanasia in suspect cases. As diagnostic technology advances, the goal is to create more accessible, reliable, and humane rabies testing methods that improve disease management and prevention across diverse settings.

What Factors Are Driving the Growth in the Rabies Diagnostics Market?

The growth in the rabies diagnostics market is driven by factors such as increasing awareness of rabies prevention, advancements in diagnostic technologies, and the rising demand for accessible diagnostics in high-risk regions. As awareness grows around the dangers of rabies and the importance of early diagnosis, healthcare authorities and veterinary organizations are prioritizing rabies diagnostic testing to control and prevent outbreaks. Furthermore, rapid urbanization in many parts of the world has increased human-wildlife interactions, raising the potential for rabies exposure and the need for widespread diagnostic capabilities.

Technological advancements have also made rabies diagnostics more accessible, with portable rapid tests and molecular testing techniques now available for field and clinical use. These innovations address the challenges of testing in remote areas, particularly in regions of Africa, Asia, and Latin America, where rabies remains endemic. Additionally, government initiatives and collaborations with non-profit organizations to reduce rabies cases globally, such as the World Health Organization’s “Zero by 30” goal to eliminate human deaths from dog-mediated rabies by 2030, have created a supportive environment for rabies diagnostics development and deployment. These combined factors are driving growth in the rabies diagnostics market, supporting efforts to reduce rabies transmission and improve public health outcomes worldwide.

SCOPE OF STUDY:

The report analyzes the Rabies Diagnostics market in terms of US$ Thousand by the following Method; Technology, and Geographic Regions/Countries:

Segments:

Method (Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations, Serology Tests); Technology (ELISA / Immunohistochemistry, Chromatography, PCR, Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbexa Ltd.
  • Aviva Systems Biology Corporation
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Creative Diagnostics
  • Demeditec Diagnostics GmbH
  • Express Biotech International Inc.
  • Merck KGaA
  • MyBioSource.com
  • Norgen Biotek Corp.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Rabies Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Rabies in Developing Regions Drives Demand for Advanced Rabies Diagnostic Solutions
    • Increased Focus on Zoonotic Disease Control and Prevention Spurs Growth in Rabies Diagnostics
    • Advancements in Rapid Diagnostic Techniques Enhance Accessibility and Accuracy of Rabies Testing
    • Growing Awareness Programs for Rabies Prevention and Early Detection Expand Market for Diagnostic Tools
    • Expansion of Veterinary Diagnostics for Rabies Testing in Domestic and Wild Animals Supports Market Growth
    • Technological Innovations in Point-of-Care (POC) Rabies Testing Boost Adoption in Remote and Low-Infrastructure Regions
    • Rising Adoption of Molecular Diagnostic Techniques Strengthens Accuracy and Sensitivity of Rabies Diagnostics
    • Growing Use of Immunohistochemistry (IHC) and ELISA Techniques in Rabies Diagnostics Expands Laboratory Testing Market
    • Increasing Prevalence of Rabies in Asia and Africa Spurs Demand for Field-Ready Diagnostic Tools
    • Rising Demand for Cost-Effective and User-Friendly Diagnostic Kits Expands Accessibility in Low-Resource Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Rabies Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Fluorescent Antibody Tests (FAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Fluorescent Antibody Tests (FAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Fluorescent Antibody Tests (FAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Immunohistochemical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Immunohistochemical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Immunohistochemical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Amplification Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Amplification Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Amplification Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Histologic Examinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Histologic Examinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Histologic Examinations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Serology Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for ELISA / Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for ELISA / Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for ELISA / Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 31: World Rabies Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Rabies Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Rabies Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • INDIA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Rabies Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Rabies Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030
  • AFRICA
    • Rabies Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION